Immunovaccine Inc. (TSX-V: IMV) has appointed James W. Hall to its Board of Directors. With over 25 years of financial and investment experience in
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Mr. Hall currently serves as the President and CEO of James Hall Advisors. Most recently, he was with Journal Register Company as Chairman and CEO, where he led the company through reorganization and consensual capital restructuring. He graduated from the Richard Ivey School of Business and is a Council member of Ivey’s Institute for Entrepreneurship.
Immunovaccine Inc. (TSX VENTURE:IMV) is a clinical stage vaccine development company focused on the commercialization of its patented DepoVax™ vaccine delivery technology and product candidates.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
